Ads
related to: difference between xifaxan and rifaximin- Copay Savings Card
Activate Your Xifaxan® (rifaximin)
Copay Savings Card Today.
- Resources & Support
View Downloadable Resources, The
Caregiver Corner, & FAQs.
- About Xifaxan®(rifaximin)
See Common Side Effects & Learn
More About Xifaxan® (rifaximin).
- Healthcare Professionals
Obtain Product Information
Relevant To Your Patients
- Copay Savings Card
Search results
Results From The WOW.Com Content Network
Rifaximin, sold under the brand name Xifaxan among others, is a non-absorbable, broad-spectrum antibiotic mainly used to treat travelers' diarrhea. It is based on the rifamycin antibiotics family. Since its approval in Italy in 1987, it has been licensed in more than 30 countries for the treatment of a variety of gastrointestinal diseases like ...
About XIFAXAN® (rifaximin) 550 mg tablets. Indication for XIFAXAN® 550 mg. XIFAXAN 550 mg is a rifamycin antibacterial indicated for reduction in risk of overt hepatic encephalopathy (HE ...
The rifamycin group includes the classic rifamycin drugs as well as the rifamycin derivatives rifampicin (or rifampin), rifabutin, rifapentine, rifalazil and rifaximin. Rifamycin, sold under the trade name Aemcolo, is approved in the United States for treatment of travelers' diarrhea in some circumstances. [1] [2] [3]
Most Medicare Part D plans and Part C plans that include drug coverage cover rifaximin (Xifaxan) for irritable bowel syndrome with diarrhea (IBS-D) and overt hepatic encephalopathy (HE). According ...
Medicare Part D prescription drug coverage helps cover the cost of Xifaxan (rifaximin). Doctors may recommend Xifaxan to treat irritable bowel syndrome with diarrhea (IBS-D) or to help prevent ...
When rifaximin is added to lactulose, the combination of the two may be more effective than each component separately. [4] Rifaximin is more expensive than lactulose, but the cost may be offset by fewer hospital admissions for encephalopathy. [19] The antibiotics neomycin and metronidazole are other antibiotics used to treat hepatic ...
A Cochrane review found no difference in efficacy between a 3- to 4-month regimen of rifampicin and a 6-month regimen of isoniazid for preventing active tuberculosis in patients not infected with HIV, and patients who received rifampicin had a lower rate of hepatotoxicity. [15] However, the quality of the evidence was judged to be low. [15]
Salix Pharmaceuticals Previews American College of Gastroenterology 2012 RALEIGH, N.C.--(BUSINESS WIRE)-- Salix Pharmaceuticals, Ltd. (NAS: SLXP) today announced that educational activities and ...
Ad
related to: difference between xifaxan and rifaximin